0001019056-21-000353.txt : 20210602 0001019056-21-000353.hdr.sgml : 20210602 20210602193214 ACCESSION NUMBER: 0001019056-21-000353 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210601 FILED AS OF DATE: 20210602 DATE AS OF CHANGE: 20210602 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Abdun-Nabi Daniel CENTRAL INDEX KEY: 0001380187 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37746 FILM NUMBER: 21990827 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DRIVE STREET 2: SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aptevo Therapeutics Inc. CENTRAL INDEX KEY: 0001671584 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811567056 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-838-0500 MAIL ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 abdunnabi.xml X0306 4 2021-06-01 0 0001671584 Aptevo Therapeutics Inc. APVO 0001380187 Abdun-Nabi Daniel C/O APTEVO THERAPEUTICS INC. 2401 4TH AVENUE, SUITE 1050 SEATTLE WA 98121 1 0 0 0 Stock Option (right to buy) 26.15 2021-06-01 4 A 0 2678 0 A 2031-06-01 Common Stock 2678 2678 D Restricted Stock Unit 2021-06-01 4 A 0 893 0 A Common Stock 893 893 D The option vests in three approximately equal annual installments beginning on June 1, 2022. Restricted stock units (the "RSUs") convert into shares of the Issuer's common stock on a one-for-one basis. The RSUs vest in three approximately equal annual installments beginning on June 1, 2022. /s/ Carl A. Valenstein, attorney-in-fact 2021-06-02